Lung cancer and radiofrequency ablation

Journal of Vascular and Interventional Radiology

Volumn 17, Issue 6, 2006, Pages 927-951

  Rose, Steven C ^a   Thistlethwaite, Patricia A ^a   Sewell, Patrick E ^b   Vance, Ralph B ^b  

^a UCSD MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM DERIVATIVE;

ALGORITHM; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; HISTORY OF MEDICINE; HUMAN; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; META ANALYSIS; NONHUMAN; PATIENT SAFETY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; SURGICAL RISK; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING; UNITED STATES;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; DISEASE MODELS, ANIMAL; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT SELECTION; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748319668     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000222707.44902.66     Document Type: Review

References (141)

1. Jemal A, Taylor M, Ward E, et al. Cancer Statistics 2005. CA Cancer J Clin 2005; 55:10-30.
2. Boring CC, Squires TS, Tong T, et al. Cancer Statistics, 1994. CA Cancer J Clin 1994; 44:7-26.
3. American Cancer Society. Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society, 2005.
4. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89(suppl):225S-233S.
5. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717.
6. Non-Small Cell Lung Cancer (PDQ®): Treatment. Bethesda, MD: National Cancer Institute, U.S. National Institute of Health, 2005.
7. Lung. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002; 167-181.
8. Figlin RA, Holmes EC, Turrisi AT, et al. Neoplasms of the lung, pleura, and mediastinum. In: Haskell CM, ed. Cancer Treatment. 4th ed. Philadelphia: WB Saunders, 1995; 385-413.
9. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350:379-392.
10. Burt M, Martini N, Ginsberg RJ. Surgical treatment of lung carcinoma. In: Baue AE, ed. Glenn's thoracic and cardiovascular surgery. 6th ed. Stamford, CT: Appleton & Lange, 1996; 421-443.
11. Ginsberg RJ, Port JL. Surgical therapy of stage I, and non-T3 NO stage II non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, et al, eds. Lung cancer: principles and practice of oncology. 2 nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000; 682-693.
12. Ihde DC, Pass HI, Glatstein E. Small cell lung cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven, 1997; 911-949.
13. Deslauriers J. Current surgical treatment of nonsmall cell lung cancer 2001. Eur Respir J 2002; 19(suppl):61S-70S.
14. Boysen PG, Block AJ, Moulder PV. Relationship between preoperative pulmonary function tests and complications after thoracotomy. Surg Gynecol Obstet 1981; 152:813-815.
15. Sewell PE, Schwartz JH, Vance RB, et al. Radiofrequency ablation of primary lung cancer; survival at three years. Tech Vasc Interv Radiol 2006 (in press).
16. Ginsberg RJ, Rubinstein LV. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 NO nonsmall cell lung cancer. Ann Thorac Surg 1995; 60:615-623.
17. Winton T, Livingston R, Johnson D, et al for the National Cancer Institute of Canada Clinical Trials Group and the National Cancer Institute of the United States Intergroup JBR. 10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589-2597.
18. Marshall MC, Olsen GN. The physiologic evaluation of the lung resection candidate. Clin Chest Med 1993; 14:305-320.
19. Martinez FJ, Iannettoni M, Paine R II. Medical evaluation and management of the lung cancer patient prior to surgery, radiation, or chemotherapy. In: Pass HI, Mitchell JB, Johnson DH, et al, eds. Lung cancer: principles and practice of oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2000; 649-681.
20. Zierhut D, Bettscheider C, Schubert K, et al. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer 2001; 34:39-43.
21. Robinson LA, Wagner H Jr, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003; 123(suppl):202S-220S.
22. Jett JR, Scott WJ, Rivera MP, et al. Guidelines on treatment of stage IIIB non-small cell lung cancer. American College of Chest Physicians. Chest 2003; 123(suppl):221S-225S.
23. Socinski MA, Morris DE, Masters GA, et al. Chemotherapeutic management of stage IV non-small cell lung cancer. American College of Chest Physicians. Chest 2003; 123(suppl):226S-243S.
24. Schiller JH, Harrington D, Belani CP, et al, for the Eastern Cooperative Oncology 11 Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346:92-98.
25. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655.
26. Feld R, Ginsberg RJ, Payne DG, et al. Lung. In: Abeloff MD, Armitage JO, Lichter AS, et al, eds. Clinical oncology. New York: Churchill Livingstone, 1995:1083-1152.
27. Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. American Society of Clinical Oncology. J Clin Oncol 2004; 22:330-353.
28. Price A. Lung cancer. 5: state of the art radiotherapy for lung cancer. Thorax 2003; 58:447-452.
29. Budach W, Belka C. Palliative percutaneous radiotherapy in non-smallcell lung cancer. Lung Cancer. 2004; 45(suppl 2):S239-S245.
30. Lassen V, Hansen H. Small cell carcinoma of the lung. In: Haskell CM, ed. Cancer treatment. 4th ed. Philadelphia: WB Saunders, 1995;414-420.
31. Willis RA. Secondary tumours of the lungs. In: Willis RA. The spread of tumours in the human body. London: Butterworths, 1973;167-174.
32. Pastorino U, Buyse M, Friedel G. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases Writing Committee. J Thor Cardiovasc Surg 1997; 113:37-49.
33. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002; 124:1007-1013.
34. Morgan-Parkes JH. Metastases: mechanisms, pathways, and cascades. AJR Am J Roentgenol 1995; 164:1075-1082.
35. Pass HI, Donington JS. Metastatic cancer to the lung. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997;2536-2551.
36. Chen PW, Pass HI. Indications for resection of pulmonary metastases: In: Baue AE. Glenn's thoracic and cardiovascular surgery, sixth edition. Stamford, CT: Appleton & Lange, 1996;499-510.
37. Landreneau RJ, De Giacomo T, Mack MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg 2000; 18:671-677.
38. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984; 38:323-330.
39. Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002; 22:335-344.
40. Lencioni RA, Crocetti L, Glenn DW, et al. Radiofrequency Ablation of Pulmonary Tumors Responses Evaluation (RAPTURE) trial [abstract]. Radiology 2004; 233(suppl):657.
41. Schneider P, Kampfer S, Loddenkemper C, et al. Chemoembolization of the lung improves tumor control in a rat model. Clin Cancer Res 2002; 8:2463-2468.
42. Vogl TJ, Wetter A, Lindemayr S, et al. Treatment of unresectable lung metastases with transpulmonary chemoembolization: preliminary experience. Radiology 2005; 234:917-922.
43. Goldberg SN, Charboneau JW, Dodd GD III, et al. International Working Group on Image-Guided Tumor Ablation. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228:335-345.
44. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633-646.
45. Goldberg NS, Dupuy DE. Imageguided radiofrequency tumor ablation: challenges and opportunities-part I. J Vasc Interv Radiol 2001; 12:1021-1032.
46. McGahan JP, Browning PD, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-270.
47. McGahan JP, Brock JM, Tesluk H, et al. Hepatic ablation with use of radiofrequency electrocautery in the animal model. J Vasc Interv Radiol 1992; 3:291-297.
48. Kruskal JB, Oliver B, Huertas JC, et al. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Interv Radiol 2001; 12:1193-1201.
49. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. 1948. J Appl Physiol 1998; 85:5-34.
50. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
51. Brown DB. Concepts, considerations, and concerns on the cutting edge of radiofrequency ablation. J Vasc Interv Radiol 2005; 16:597-613.
52. Goldberg SN, Gazelle GS, Dawson SL, et al. Tissue ablation with radiofrequency: effect of probe size, gauge, duration, and temperature on lesion volume. Acad Radiol 1995; 2:399-404.
53. Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004; 230:761-767.
54. Goldberg SN, Gazelle GS, Halpern EF, et al. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-218.
55. de Baere T, Denys A, Wood BJ, et al. Radiofrequency liver ablation: experimental comparative study of watercooled versus expandable systems. AJR Am J Roentgenol 2001; 176:187-192.
56. Lu DS, Raman SS, Limanond P, et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003; 14:1267-1274.
57. Shirabe K, Takenaka K, Gion T, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997; 84:1077-1080.
58. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998; 24:174-179.
59. Dodd GD III, Frank MS, Aribandi M, et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177:777-782.
60. Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients? mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232:260-271.
61. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170:1015-1022.
62. Arata MA, Nisenbaum HL, Clark TW, et al. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol 2001; 12:455-458.
63. Goldberg SN, Solbiati L, Hahn PF, et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998; 209:371-379.
64. Haemmerich D, Lee FT Jr, Schutt DJ, et al. Large-volume radiofrequency ablation of ex vivo bovine liver with multiple cooled cluster electrodes. Radiology 2005; 234:563-568.
65. Goldberg SN, Stein MC, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: optimization of pulsed-radiofrequency technique to increase coagulation necrosis. J Vasc Interv Radiol 1999; 10:907-916.
66. Lin SM, Lin CJ, Chung HJ, et al. Power rolloff during interactive radiofrequency ablation can enhance necrosis when treating hepatocellular carcinoma. AJR Am J Roentgenol 2003; 180:151-157.
67. Goldberg SN, Ahmed M, Gazelle GS, et al. Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology 2001; 219:157-165.
68. Kurokohchi K, Watanabe S, Masaki T, et al. Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocellular carcinoma. Int J Oncol 2002; 21:841-846.
69. Kettenbach J, Kostler W, Rucklinger E, et al. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 2003; 180:1537-1545.
70. Livraghi T, Goldberg SN, Monti F, et al. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology 1997; 202:205-210.
71. Ahmed M, Weinstein J, Liu Z, et al. Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model. J Vasc Interv Radiol 2003; 14:1045-1052.
72. Shankar S, vanSonnenberg E, Morrison PR, et al. Combined radiofrequency and alcohol injection for percutaneous hepatic tumor ablation. AJR Am J Roentgenol 2004; 183:1425-1429.
73. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217:119-126.
74. Yamakado K, Nakatsuka A, Ohmori S, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13:1225-1232.
75. Kitamoto M, Imagawa M, Yamada H, et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 2003; 181:997-1003.
76. Vogl TJ, Mack MG, Balzer JO, et al. Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 2003; 229:457-464.
77. Sugimori K, Nozawa A, Morimoto M, et al. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model. J Vasc Interv Radiol 2005; 16:849-856.
78. Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001; 176:789-795.
79. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230:1-8.
80. Miyamoto N, Tsuji K, Sakurai Y, et al. Percutaneous radiofrequency ablation for unresectable large hepatic tumours during hepatic blood flow occlusion in four patients. Clin Radiol 2004; 59:812-818.
81. Stippel DL, Brochhagen HG, Arenja M, et al. Variability of size and shape of necrosis induced by radiofrequency ablation in human livers: a volumetric evaluation. Ann Surg Oncol 2004; 11:420-425.
82. Laeseke P, Brace CL, Sampson LA, et al. Radiofrequency ablation with multiple electrodes: initial clinical experience [abstract]. Radiology 2005; 233(suppl):76.
83. Solbiati L, Ierace T, Bellobuono A, et al. Simultaneous cool tip multiprobe RF ablation of multiple liver malignancies under real-time biplane sonographic guidance [abstract]. Radiology 2005; 233(suppl):76.
84. Clasen S, Schmidt D, Boss A, et al. Bipolar radiofrequency ablation using internally cooled electrodes: an experimental study in ex-vivo bovine liver [abstract]. Radiology 2005; 233(suppl):76.
85. Mack MG, Luder-Luhr T, Eichler K, et al. Bipolar radiofrequency ablation of lung metastases [abstract]. Radiology 2005; 233(suppl):81.
86. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230:125-134.
87. Dupuy DE, Mayo-Smith WW, Abbott GF, et al. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002; 22:259-269.
88. Ahmed M, Lukyanov AN, Torchilin V, et al. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 2005; 16:1365-1371.
89. Chin MC, Rosenqvist M, Lee MA, et al. The effect of radiofrequency catheter ablation on permanent pacemakers: an experimental study. Pacing Clin Electrophysiol 1990; 13:23-29.
90. Tong NY, Ru HJ, Ling HY, et al. Extracardiac radiofrequency ablation interferes with pacemaker function but does not damage the device. Anesthesiology 2004; 100:1041-.
91. Hayes DL, Charboneau JW, Lewis BD, et al. Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers. Mayo Clin Proc 2001; 76:950-952.
92. Liao WY, Chen MZ, Chang YL, et al. US-guided transthoracic cutting biopsy for peripheral thoracic lesions less than 3 cm in diameter. Radiology 2000; 217:685-691.
93. Wacker FK, Reither K, Ritz JP, et al. MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging 2001; 13:31-36.
94. Vogl TJ, Straub R, Eichler K, et al. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology 2002; 225:367-377.
95. Wacker FK, Nour SG, Eisenberg R, et al. MRI-guided radiofrequency thermal ablation of normal lung tissue: in vivo study in a rabbit model. AJR Am J Roentgenol 2004; 183:599-603.
96. Silverman SG, Sun MR, Tuncali K, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol 2004; 183:707-712.
97. Lencioni R, Crocetti L, Cioni R, et al. Radiofrequency ablation of lung tumors: value of multiplanar CT imaging for optimizing treatment protocol [abstract]. Radiology 2003; 229(suppl):G02-548.
98. Shankar S, van Sonnenberg E, Silverman SG, et al. Brachial plexus injury from CT-guided RF ablation under general anesthesia. Cardiovasc Intervent Radiol 2005; 28:646-648.
99. Goldberg SN, Solbiati L, Halpern EF, et al. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000; 11:1069-1075.
100. Friedman M, Mikityansky I, Kam A, et al. Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol 2004; 27:427-434.
101. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004; 183:361-368.
102. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005; 185:466-471.
103. Sewell PE Jr. Percutaneous radiofrequency ablation of primary and secondary pulmonary malignancies using CT guidance [abstract]. Radiology 2000; 217(suppl):291.
104. Sewell PE Jr, Vance RB, Wang YD. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography (PET) [abstract]. Radiology 2000; 1217(suppl):334.
105. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463-470.
106. Goldberg SN, Walovitch RC, Straub JA, et al. Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent. Radiology 1999; 213:438-444.
107. Morimoto M, Sugimori K, Shirato K, et al. Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods. Hepatology 2002; 35:1467-1475.
108. Yamashiki N, Kato T, Bejarano P, et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastoenterol 2003; 98:2052-2059.
109. Goldberg SN, Gazelle GS, Compton CC, et al. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2:776-784.
110. Morrison PR, van Sonnenberg E, Shankar S, et al. Radiofrequency ablation of thoracic lesions: part 1, experiments in the normal porcine thorax. AJR Am J Roentgenol 2005; 184:375-380.
111. Nomori H, Imazu Y, Watanabe K, et al. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest 2005; 127:973-977.
112. Goldberg SN, Gazelle GS, Compton CC, et al. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996; 3:929-935.
113. Lee JM, Jin GY, Li CA, et al. Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness. Invest Radiol 2003; 38:129-139.
114. Miao Y, Ni Y, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001; 99:265-271.
115. Ahrar K, Price RE, Wallace MJ, et al. Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol 2003; 14:1037-1043.
116. Tominaga J, Miyachi H, Tekase K, et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol 2005; 16:1719-1726.
117. Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-59.
118. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125:929-937.
119. Suh RD, Wallace AB, Sheehan RE, et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology 2003; 229:821-829.
120. Steinke K, King J, Glenn D, et al. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27:750-757.
121. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CTguided radiofrequency ablation: initial experience. Radiology 2004; 231:850-857.
122. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer - a preliminary report of 33 patients. AJR Am J Roentgenol 2004; 183:1003-1011.
123. Kang S, Luo R, Liao W, et al. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol 2004; 2:30-.
124. van Sonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience? technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005; 184:381-390.
125. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644.
126. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
127. Solbiati L, Goldberg SN, Ierace T, et al. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent? early experience. Radiology 1999; 211:643-649.
128. Raman SS, Lu DS, Vodopich DJ, et al. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 2000; 175:1253-1258.
129. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217:558-563.
130. Chopra S, Dodd GD 3rd, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 2001; 177:381-387.
131. Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001; 177:783-788.
132. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001; 177:375-380.
133. Kim SK, Lim HK, Kim YH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003; 23:107-121.
134. Morimoto M, Nozawa A, Numata K, et al. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 2005; 24:273-283.
135. Sacks D, McClenny TE, Cardella JF, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003; 14(suppl):S199-S202.
136. Kinney TB, Chen HT, Rose SC, et al. Complications of thoracic intervention: evaluation of contributory factors [abstract]. J Vasc Interv Radiol 2003; 14(suppl):S89.
137. Hiraki T, Yasui K, Mimura H, et al. Radiofrequency ablation of metastatic mediastinal lymph nodes during cooling and temperature monitoring of the tracheal mucosa to prevent thermal tracheal damage: initial experience. Radiology 2005; 237:1068-1074.
138. Rose SC, Fotoohi M, Levin DL, et al. Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol 2002; 13:1051-1054.
139. Yamamoto A, Matsuoka T, Toyoshima M, et al. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging. AJR Am J Roentgenol 2004; 183:1785-1789.
140. Jin GY, Lee JM, Lee YC, et al. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor. AJR Am J Roentgenol 2004; 182:990-992.
141. Yamakado K, Akeboshi M, Nakatsuka A, et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 2005; 28:530-532.